Literature DB >> 28091678

Pepsin egg white hydrolysate modulates gut microbiota in Zucker obese rats.

Teresa Requena1, Marta Miguel1, Marta Garcés-Rimón1, M Carmen Martínez-Cuesta1, Rosina López-Fandiño1, Carmen Peláez1.   

Abstract

There is limited information that relates the intake of food-derived bioactive peptides and the gut microbiota. We have previously described a pepsin hydrolysate of egg white (EWH) that ameliorates fat accumulation and dyslipidemia, while reducing oxidative stress and inflammation markers in obese Zucker rats. The aim of this study was to associate the beneficial effects of EWH with gut microbiota changes in these animals. Obese Zucker rats received daily 750 mg kg-1 EWH in drinking water for 12 weeks and faeces were analysed for microbial composition and metabolic compounds in comparison with Zucker lean rats and obese controls. EWH supplementation modulated the microbiological characteristics of the obese rats to values similar to those of the lean rats. Specifically, counts of total bacteria, Lactobacillus/Enterococcus and Clostridium leptum in EWH fed obese Zucker rats were more similar to the lean rats than to the obese controls. Besides, feeding the obese Zucker rats with EWH reduced (P < 0.05) the faecal concentration of lactic acid. The physiological benefits of EWH in the improvement of obesity associated complications of Zucker rats could be associated with a more lean-like gut microbiota and a tendency to diminish total short-chain fatty acids (SCFA) production and associated obesity complications. The results warrant the use of pepsin egg white hydrolysate as a bioactive food ingredient.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28091678     DOI: 10.1039/c6fo01571a

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  6 in total

1.  Egg White Hydrolysate as a functional food ingredient to prevent cognitive dysfunction in rats following long-term exposure to aluminum.

Authors:  Caroline Silveira Martinez; Caroline D C Alterman; Gema Vera; Antonio Márquez; José-A Uranga; Franck Maciel Peçanha; Dalton Valentim Vassallo; Christopher Exley; Pâmela B Mello-Carpes; Marta Miguel; Giulia Alessandra Wiggers
Journal:  Sci Rep       Date:  2019-02-12       Impact factor: 4.379

Review 2.  Peptides from Natural or Rationally Designed Sources Can Be Used in Overweight, Obesity, and Type 2 Diabetes Therapies.

Authors:  Mayara C F Gewehr; Renata Silverio; José Cesar Rosa-Neto; Fabio S Lira; Patrícia Reckziegel; Emer S Ferro
Journal:  Molecules       Date:  2020-02-29       Impact factor: 4.411

Review 3.  Recent Advances in Applications of Bioactive Egg Compounds in Nonfood Sectors.

Authors:  Xiaoying Zhang; Brindha Chelliappan; Rajeswari S; Michael Antonysamy
Journal:  Front Bioeng Biotechnol       Date:  2021-12-16

Review 4.  The Functional Interplay between Gut Microbiota, Protein Hydrolysates/Bioactive Peptides, and Obesity: A Critical Review on the Study Advances.

Authors:  Simon Okomo Aloo; Deog-Hwan Oh
Journal:  Antioxidants (Basel)       Date:  2022-02-08

5.  Immune Cells and Microbiota Response to Iron Starvation.

Authors:  Marcello Chieppa; Gianluigi Giannelli
Journal:  Front Med (Lausanne)       Date:  2018-04-18

Review 6.  Egg and Soy-Derived Peptides and Hydrolysates: A Review of Their Physiological Actions against Diabetes and Obesity.

Authors:  Stepheny C de Campos Zani; Jianping Wu; Catherine B Chan
Journal:  Nutrients       Date:  2018-04-28       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.